April 19, 2014 2:33 PM ET

Healthcare Equipment and Supplies

Company Overview of Aspect Imaging

Company Overview

Aspect Imaging engages in developing and manufacturing compact benchtop magnetic resonance imaging (MRI) systems for preclinical, clinical, and industrial applications. The company offers M2 compact high-performance MRI platform and a suite of products that enable academic researchers and pharmaceutical companies to derive insights into their biological questions. Its products are also used by various institutions for a range of in vivo, ex vivo, and in vitro applications, including high-resolution 3D anatomical, molecular, functional, and multi-modality imaging. The company also provides M2 accessories to support animal handling and physiological monitoring, which comprise specialized small...

27 Hashaked St.

Industrial Area Hevel Modi’in

Shoham,  60850


Founded in 2000


972 73 223 9000


972 3 716 5606

Key Executives for Aspect Imaging

Founder and Chief Executive Officer
Chief Technology Officer and Member of Scientific-Advisory-Board
Vice President of Research and Development
Vice President of Advanced Industrial Applications
Vice President of Marketing & Sales
Age: 53
Compensation as of Fiscal Year 2013.

Aspect Imaging Key Developments

Aspect Imaging Introduces FlowScan(TM) Continuous Drilling Fluid Measurement Platform

Aspect Imaging is introducing its FlowScan(TM) Continuous Drilling Fluid Measurement Platform at the 2014 International Association of Drilling Contractors (IADC)/SPE Annual Drilling Conference in Fort Worth, Texas. The meeting is being held from March 4, 2014 - March 6, 2014 at the Fort Worth Convention Centre in Fort Worth, Texas. The measurement and maintenance of the quality of drilling mud is a key component to the cost-effective drilling of new oil wells. Conventional methods for monitoring and measuring the quality of drilling mud are based on manual processes that are prone to error, measure only small samples and frequently clog. The FlowScan(TM) platform enables a new measurement paradigm as it is non-obstructive (measures directly through the pipe), is automated, provides continuous measurements, and enables a wide array of fluid measurements including drilling mud rheology, flow rates, and water cut on a single platform.

Aspect Imaging Announces its M2 3D MR-Based Histology Platform at the Annual Meeting of Japanese Society of Toxicological Pathology in Tokushima, Japan

Aspect Imaging is featuring its M2 3D MR-based Histology platform at the 30th Annual Meeting of the Japanese Society of Toxicological Pathology in Tokushima, Japan in the commercial exhibits, in a new technology workshop and as part of the scientific sessions. The 30 Annual Meeting of the Japanese Society of Toxicological Pathology (JSTP) is being held from January 30 - 31st, 2014 at the Awagin Hall in the Tokushima Arts Foundation For Culture in Tokushima, Japan. Non-destructive quantification of 3D structures allows specimens to be imaged and subsequently sectioned for conventional histopathology. With the company's platform, the application of 3D MRI-based histology is now a practical, affordable tool for use in drug development and safety assessment.

Aspect Imaging Launches New Family of Compact High-Performance MRI Systems at World Molecular Imaging Congress 2013

Aspect Imaging launched a complete line of compact MRI systems for a wide variety of pre-clinical applications. The three 'M'-series compact MRI systems include the M10, a new compact MRI model for pre-clinical imaging of larger species and the M3, a new compact MRI model for imaging of mice for phenotypic research. The 2 new models complement the 3D MR-based Histology system for toxicology research as well as the current M2 platform, which is being used in the Bruker ICON compact MRI system, a leading compact MRI system for mouse and rat-based pre-clinical research and drug development. The launch is taking place at the WMIC (World Molecular Imaging Congress) 2013 Annual Meeting, being held September 18 - 21, 2013 in Savannah, GA. The Aspect Imaging compact MRI platform, unlike conventional superconducting MRI systems, does not require a shielded room, cryogens, specialty plumbing or high-capacity electrical power. The 'M'-series platform features an innovative self-shielded, permanent magnet that can be placed in most settings as it does not require special infrastructure. As such, it provides the researcher or core imaging facility manager with the power of MRI but at a fraction of the cost and without the complexity and ongoing maintenance of superconducting and cryogen-free MRI installations. The three 'M'-series compact MRI systems will be on display in Aspect Imaging's booth #422 at the WMIC Exhibition Hall at the Savannah International Trade and Convention Center in Savannah, GA from September 18 - 21, 2013. As an illustration of the ease of installation and placement of the Aspect MRI platform, a live ICON compact high-performance MRI system (powered by the Aspect Imaging M2 platform) will also be demonstrating pre-clinical phenotyping in the Bruker booth (#421).

Similar Private Companies By Industry

Company Name Region
Cybro Medical Ltd. Middle East/Africa
Odem Medical Ltd. Middle East/Africa
Gerium medical Ltd. Middle East/Africa
Sure International Ltd. Middle East/Africa
Stabilodyn Ltd. Middle East/Africa

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aspect Imaging, please visit www.aspectimaging.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.